Catalyzing Innovation in Pediatric Pharmacology Clinical Trial Design and Resource Access (X01 Clinical Trial Not Allowed)

Closed Posted

Opportunity number
PAR-20-161
Agency
Applications due
Award size
Not on record

Opportunity facts

Assistance listings
Funding instrument
Grant
Categories
  • Health
  • Income Security and Social Services
Eligible applicants
  • Higher Education Inst. (Public)
  • For Profit Organizations
  • Tribal Organizations (Not Federally Recognized)
  • City/Township Governments
  • Tribal Governments (Federally Recognized)
  • Small Businesses
  • Special District Governments
  • Higher Education Inst. (Private)
  • State Governments
  • Non-501(c)(3) Nonprofits
  • Other
  • Independent School Districts
  • 501(c)(3) Nonprofits
  • Public or Indian Housing Auth.
  • County Governments
Full announcement

Opportunity details come from Grants.gov. Updated .

Synopsis

The purpose of this funding opportunity announcement (FOA) is to provide investigators with access to a consultative resource for planning activities and concept development for single or multi-site investigator initiated clinical trials that address gaps in pediatric drug development and that align with priorities identified in the Best Pharmaceuticals for Children Act (BPCA) Program. The FOA will support the development of clinical trials concepts of future well-designed clinical trials that require non-traditional designs in pediatric therapeutics with the opportunity to expand novelty and/or innovation. Investigators will have access to the expertise in pediatric drug development trial designs by utilizing the consultative services provided by the Pediatric Trials Network (PTN) and the BPCA Data Coordinating Center.

Files

File Type Posted
PAR-20-161-Full-Announcement.html HTML file
PKG00260723-instructions.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity
Try for free Login